China Shineway Pharmaceutical Group Limited

HKEX:2877.HK

7.86 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 4,516.5383,950.6363,223.552,655.7012,705.9962,570.1961,919.6081,993.3792,054.8092,229.2012,187.1152,132.2491,984.5422,038.3791,633.2231,275.1791,012.885841.475831.379703.575604.042
Cost of Revenue 1,122.4191,012.322813.214667.855724.431694.149652.524706.884693.89751.198712.692740.303682.459603.371455.132360.862274.847249.175274.772251.998315.002
Gross Profit 3,394.1192,938.3142,410.3361,987.8461,981.5651,876.0471,267.0841,286.4951,360.9191,478.0031,474.4231,391.9461,302.0831,435.0081,178.091914.317738.038592.3556.607451.577289.04
Gross Profit Ratio 0.7510.7440.7480.7490.7320.730.660.6450.6620.6630.6740.6530.6560.7040.7210.7170.7290.7040.6690.6420.479
Reseach & Development Expenses 110.462117.454112.71199.705102.715128.12696.51173.59268.93280.41983.28868.04657.38721.87333.397000000
General & Administrative Expenses 326.499279.804256.557273.359275.663256.274247.289277.654302.307285.403262.025252.762229.244196.669136.06699.980.92967.7271.45555.11734.728
Selling & Marketing Expenses 1,981.6231,818.6521,499.6821,185.4691,126.707997.351515.216370.65375.492411.658439.137423.258255.398350.132353.2276.338258.0790000
SG&A 2,308.1222,107.2841,763.261,465.7431,402.371,253.625762.505648.304677.799697.061701.162676.02484.642546.801489.266376.238339.00867.7271.45555.11734.728
Other Expenses 167.382104.9882.85386.16886.14738.7724.7484.7438.5225.7491.5830.268-189.4462.3146.14532.7207.24146.30218.2090.8590.805
Operating Expenses 2,418.5842,119.7581,793.1181,708.8811,455.6061,340.363780.815691.819661.103727.109700.887668.045352.583491.177340.22470.803369.338251.568232.364171.627104.763
Operating Income 970.095713.576534.365422.398476.48494.296408.068564.599614.188700.523689.973675.447949.5943.831837.871443.514368.7340.732324.243279.95184.277
Operating Income Ratio 0.2150.1810.1660.1590.1760.1920.2130.2830.2990.3140.3150.3170.4780.4630.5130.3480.3640.4050.390.3980.305
Total Other Income Expenses Net 270.158203.449185.738-27.374166.292174.834179.754130.655182.977163.213169.673124.289047.97746.14532.7207.24146.30218.2090.8590.805
Income Before Tax 1,240.253917.025720.103395.024642.772669.13587.822695.254797.165863.736859.646799.736949.5991.808884.016476.214575.941387.034342.452280.809185.082
Income Before Tax Ratio 0.2750.2320.2230.1490.2380.260.3060.3490.3880.3870.3930.3750.4780.4870.5410.3730.5690.460.4120.3990.306
Income Tax Expense 270.743194.252163.42999.991139.622163.254136.269106.058139.45159.046176.004152.081193.924170.052116.71277.97285.354.0575.44610.659-7.308
Net Income 969.51722.773556.674295.033503.15505.876451.553589.196657.906704.775683.647647.704755.6821.756767.304398.242490.641332.977337.006260.793151.37
Net Income Ratio 0.2150.1830.1730.1110.1860.1970.2350.2960.320.3160.3130.3040.3810.4030.470.3120.4840.3960.4050.3710.251
EPS 1.280.960.740.390.640.620.550.710.80.850.830.780.910.990.930.480.590.40.40.420.25
EPS Diluted 1.280.960.740.390.640.620.550.710.80.850.830.780.910.990.930.480.590.40.40.420.25
EBITDA 1,425.532888.23705.114621.848672.706691.763602.712755.646776.631844.845788.033757.4491,015.183996.858883.198479.555400.784370.465350.035302.234206.233
EBITDA Ratio 0.3160.2250.2190.2340.2490.2690.3140.3790.3780.3790.360.3550.5120.4890.5410.3760.3960.440.4210.430.341